Finance

Lists
XPEV:NYSE
Xpeng Inc - ADR
USD 9,50
+1,06%
(+0,10) 1D
6 Okt., 11:44:46 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XPEV...
Open
USD 9,48
High
USD 9,53
Low
USD 9,44
Mkt. cap
8,97 mjd
Avg. vol.
7,61 m
Volume
1,68 m
52-wk high
USD 28,24
52-wk low
USD 9,18
EPS
-USD 0,49
Beta
1,07
Shares outstanding
785,11 m
No. of employees
21 k
Open
USD 9,48
High
USD 9,53
Low
USD 9,44
Mkt. cap
8,97 mjd
Avg. vol.
7,61 m
Volume
1,68 m
52-wk high
USD 28,24
52-wk low
USD 9,18
EPS
-USD 0,49
Beta
1,07
Shares outstanding
785,11 m
No. of employees
21 k
News stories
From web sources and news partners
About Xpeng Inc - ADR
CEO-
Employees20,6 k
Founded2015
Headquarters-
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to XPEV in the past 3 months
Buy
Buy
5
Hold
3
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for XPEV in the last 3 months.
Highest
Current USD 9,50
USD 28,00 (+194,58%)
Average
USD 17,88 (+88,11%)
Lowest
USD 11,50 (+20,99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Nick Lai
J.P. Morgan
Hold
Downgraded
USD 11,50
+21%
09/29/2026
Paul Gong
UBS
Hold
Reiterated
USD 12,00
+26,2%
09/09/2026
Jiong Shao
Barclays
Sell
Reiterated
USD 14,00
+47,3%
08/25/2026
Jeff Chung
Citi
Buy
Maintained
USD 21,40
+125,1%
08/24/2026
Ji Shi
CMB International Securities
Buy
Maintained
USD 16,00
+68,3%
08/25/2026
Unknown Analyst
DBS
Buy
Maintained
USD 28,00
+194,6%
08/25/2026
Ming-Hsun Lee
Bank of America Securities
Buy
Reiterated
USD 18,00
+89,4%
08/24/2026
Neil Beveridge
Bernstein
Hold
Maintained
USD 20,00
+110,4%
08/17/2026
Unknown Analyst
UBS
Hold
Maintained
-
-
08/12/2026
Unknown Analyst
Goldman Sachs
Buy
Maintained
USD 20,00
+110,4%
08/03/2026
Eugene Hsiao
Macquarie
Buy
Upgraded
USD 19,00
+99,9%
05/28/2026
Eunice Lee
Bernstein
Hold
Maintained
USD 22,00
+131,5%
05/11/2026
Johnson Wan
Jefferies
Buy
Reiterated
USD 26,50
+178,8%
03/25/2026
Unknown Analyst
Jefferies
Buy
Reiterated
USD 26,50
+178,8%
03/25/2026
Bo Pei CFA
US Tiger Securities
Hold
Downgraded
USD 20,00
+110,4%
03/20/2026
Tim Hsiao
Morgan Stanley
Buy
Maintained
USD 34,00
+257,7%
03/09/2026
Last report
24 Aug. 2026
Fiscal period
Q2 2026
EPS / Est. (CNY)
-CNÂ¥0,65 / -CNÂ¥0,48
-35,42%miss
Revenue / Est. (CNY)
19,74 mjd / 20,50 mjd
-3,67%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
20,38 mjd
22,25 mjd
13,03 mjd
19,74 mjd
Cost of goods sold
16,28 mjd
17,40 mjd
10,35 mjd
15,66 mjd
Cost of revenue
16,28 mjd
17,40 mjd
10,35 mjd
15,66 mjd
Research and development expenses
2,43 mjd
2,87 mjd
2,91 mjd
2,91 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,49 mjd
2,79 mjd
1,88 mjd
2,50 mjd
Operating expense
4,78 mjd
4,83 mjd
4,61 mjd
5,27 mjd
Total operating expenses
21,06 mjd
22,23 mjd
14,96 mjd
20,93 mjd
Operating income
-677,22 m
24,47 m
-1,93 mjd
-1,19 mjd
Other non operating income
-1,11 m
22,17 m
-1,06 m
49,37 m
EBT including unusual items
-387,98 m
405,34 m
-1,77 mjd
-1,26 mjd
EBT excluding unusual items
-445,27 m
208,70 m
-2,00 mjd
-1,17 mjd
Income tax expense
-7,11 m
22,13 m
9,25 m
74,28 m
Effective tax rate
1,83%
5,46%
-0,52%
-5,88%
Other operating expenses
-140,28 m
-839,69 m
-182,25 m
-137,25 m
Net income
-380,87 m
383,21 m
-1,78 mjd
-1,34 mjd
Net profit margin
-1,87%
1,72%
-13,69%
-6,77%
Earnings per share
-0,16
0,52
-0,88
-0,65
Interest and investment income
300,84 m
262,92 m
257,17 m
216,75 m
Interest expense
-99,35 m
-76,48 m
-164,99 m
-124,47 m
Net interest expenses
201,49 m
186,43 m
92,17 m
92,27 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-137,40 m
593,24 m
-1,36 mjd
-621,42 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme